Lamotrigine Open Trial in Refractory Epilepsy
Lamotrigine, 5 and 15 mg/kg/daily, was administered as add-on therapy in 37 outpatient children and adolescents with refractory epilepsy and mental delay treated at the Child Neuropsychiatry Unit, Department of Pediatrics, Second University of Naples, Italy.
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pediatric Neurology Briefs Publishers
1997-10-01
|
| Series: | Pediatric Neurology Briefs |
| Subjects: | |
| Online Access: | https://www.pediatricneurologybriefs.com/articles/2359 |